Envista Holdings Quick Ratio (NVST) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Envista Holdings Corporation  (NYSE: NVST)

Envista Holdings's Quick Ratio

NVST's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Envista Holdings's Cash & cash equivalent grew by 3.95 % in the Q2 2026 sequentially, faster than Current Liabilities, this led to improvement in Envista Holdings's Quick Ratio to 1.39, above Envista Holdings Corporation average Quick Ratio.

Within Medical Equipment & Supplies industry 97 other companies have achieved higher Quick Ratio than Envista Holdings in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 761 to 1688.

Explain Quick Ratio?
How much Cash & cash equivalents NVST´s has?
What are NVST´s Current Liabilities?




NVST Quick Ratio (Jul 03 2026)
Q2
(Apr 03 2026)
Q1
(Dec 31 2025)
Q4
(Sep 26 2025)
Q3
(Jun 27 2025)
Q2
Y / Y Current Liabilities Change 1.69 % -9.93 % 3.91 % -5.06 % -3.35 %
Y / Y Cash & cash equivalent Change 1.35 % 0.51 % 13.34 % 14.39 % 7.18 %
Quick Ratio MRQ 1.39 1.38 1.33 1.38 1.4
NVST's Total Ranking # 1688 # 761 # 922 # 1248 # 1188
Seq. Current Liabilities Change 2.63 % -13.85 % 11.12 % 3.5 % -9.09 %
Seq. Cash & cash equivalent Change 3.95 % -10.64 % 6.86 % 2.1 % 3.09 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 98
Healthcare Sector # 577
Overall Market # 1688


Quick Ratio Statistics
High Average Low
1.42 0.88 0.25
(Dec 31 2025)   (Sep 27 2019)




Financial Statements
Envista Holdings's Current Liabilities $ 807 Millions Visit NVST's Balance sheet
Envista Holdings's Cash & cash equivalent $ 1,126 Millions Visit NVST's Balance sheet
Source of NVST's Sales Visit NVST's Sales by Geography


Cumulative Envista Holdings's Quick Ratio

NVST's Quick Ratio for the trailling 12 Months

NVST Quick Ratio

(Jul 03 2026)
12 Months
(Apr 03 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 26 2025)
12 Months
(Jun 27 2025)
12 Months
Y / Y Current Liabilities TTM Growth -2.42 % -3.59 % 1.65 % 3.49 % 8.8 %
Y / Y Cash & cash equivalent TTM Growth 7.2 % 8.75 % 12.07 % 12.13 % 13.32 %
Quick Ratio TTM 1.37 1.37 1.33 1.3 1.25
Total Ranking TTM # 3967 # 1858 # 2208 # 2970 # 2988
Seq. Current Liabilities TTM Growth 0.4 % -2.55 % 1.02 % -1.28 % -0.8 %
Seq. Cash & cash equivalent TTM Growth 0.33 % 0.12 % 3.25 % 3.36 % 1.78 %


On the trailing twelve months basis In Spite of the rise in Current Liabilities in the Q2 2026 to $807.30 millions, cumulative Quick Ratio remained unchanged at 1.37 above the NVST average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 200 other companies have achieved higher Quick Ratio than Envista Holdings. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 1858 to 3967.

Explain Quick Ratio?
How much Cash & cash equivalents NVST´s has?
What are NVST´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 201
Healthcare Sector # 892
Within the Market # 3967


trailing twelve months Quick Ratio Statistics
High Average Low
1.39 0.79 0.04
(Apr 03 2026)   (Sep 27 2019)




Companies with similar Quick Ratio in the quarter ending Jul 03 2026, within Medical Equipment & Supplies Industry Quick RatioJul 03 2026 MRQ Cash & cash equivalentJul 03 2026 MRQ Current Liabilities
Irhythm Holdings Inc   3.82 $ 839.951  Millions$ 219.981  Millions
Nutriband Inc   3.77 $ 3.422  Millions$ 0.907  Millions
Logicmark Inc  3.71 $ 6.596  Millions$ 1.779  Millions
Axogen inc   3.67 $ 111.412  Millions$ 30.374  Millions
Procept Biorobotics Corporation  3.60 $ 230.952  Millions$ 64.196  Millions
Heartbeam Inc   3.54 $ 8.700  Millions$ 2.460  Millions
Mimedx Group Inc   3.53 $ 135.839  Millions$ 38.498  Millions
Sensus Healthcare Inc   3.51 $ 15.186  Millions$ 4.327  Millions
Outset Medical Inc   3.35 $ 147.194  Millions$ 43.891  Millions
Inspiremd Inc   3.15 $ 30.421  Millions$ 9.646  Millions
Fractyl Health Inc   3.00 $ 47.140  Millions$ 15.736  Millions
Vivani Medical Inc   2.99 $ 19.894  Millions$ 6.659  Millions
Retractable Technologies Inc  2.98 $ 39.870  Millions$ 13.365  Millions
Neuropace Inc   2.97 $ 51.700  Millions$ 17.433  Millions
Apyx Medical Corp  2.95 $ 27.617  Millions$ 9.354  Millions
Omada Health Inc   2.94 $ 221.712  Millions$ 75.483  Millions
Clearpoint Neuro Inc   2.85 $ 29.363  Millions$ 10.313  Millions
Penumbra Inc  2.82 $ 658.795  Millions$ 233.776  Millions
Glaukos Corp  2.80 $ 286.594  Millions$ 102.329  Millions
Pulmonx Corporation  2.76 $ 56.393  Millions$ 20.405  Millions
Intuitive Surgical Inc   2.71 $ 5,216.200  Millions$ 1,922.900  Millions
Neuraxis Inc   2.69 $ 8.342  Millions$ 3.096  Millions
Edwards Lifesciences Corporation  2.68 $ 4,291.700  Millions$ 1,604.100  Millions
Modular Medical Inc  2.63 $ 3.920  Millions$ 1.489  Millions
Co diagnostics Inc   2.55 $ 7.299  Millions$ 2.863  Millions
Staar Surgical Co  2.47 $ 181.489  Millions$ 73.394  Millions
Electromed Inc   2.35 $ 20.450  Millions$ 8.714  Millions
EBR Systems, Inc.  2.18 $ 113.533  Millions$ 52.023  Millions
Medinotec Inc   2.15 $ 2.519  Millions$ 1.171  Millions
Atricure Inc   2.05 $ 167.786  Millions$ 81.916  Millions

Date modified: 2026-09-08T15:11:45+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.